TLR4 and neoplasm: Our results provide first evidence that the expression of TLR4 and pSTAT3 on circulating tumor cells (CTCs) and immune cells of BC patients might play a role in peripheral anti-tumor response and metastatic progression, and could be associated with patient outcomes.